MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.
Gounder M, Johnson M, Heist RS, Shapiro GI, Postel-Vinay S, Wilson FH, Garralda E, Wulf G, Almon C, Nabhan S, Aguado-Fraile E, He P, Romagnoli M, Hossain M, Narayanaswamy R, Sadou-Dubourgnoux A, Cooper M, Askoxylakis V, Burris HA, Tabernero J.
Gounder M, et al. Among authors: he p.
Nat Commun. 2025 Jan 6;16(1):423. doi: 10.1038/s41467-024-55316-5.
Nat Commun. 2025.
PMID: 39762248
Free PMC article.
Clinical Trial.